CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 12, Pages 1377-1392
Publisher
Informa UK Limited
Online
2016-10-28
DOI
10.1080/13543784.2016.1254615
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCR5 blockade for neuroinflammatory diseases — beyond control of HIV
- (2016) Guillaume Martin-Blondel et al. Nature Reviews Neurology
- Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists
- (2015) Suwen Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase
- (2015) Bryan D. Cox et al. ACS Medicinal Chemistry Letters
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation
- (2014) Lambros Kordelas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection
- (2013) Maria C. Puertas et al. AIDS
- Virological and Immunological Response to Antiretroviral Regimens Containing Maraviroc in HIV Type 1-Infected Patients in Clinical Practice: Role of Different Tropism Testing Results and of Concomitant Treatments
- (2013) Barbara Rossetti et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Does Total Body Irradiation Conditioning Improve Outcomes of Myeloablative Human Leukocyte Antigen–Identical Sibling Transplantations for Chronic Lymphocytic Leukemia?
- (2013) Mitchell Sabloff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Design, synthesis, and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitors
- (2013) Suwen Hu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lack of Prophylactic Efficacy of Oral Maraviroc in Macaques despite High Drug Concentrations in Rectal Tissues
- (2013) I. Massud et al. JOURNAL OF VIROLOGY
- Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists
- (2013) Tao Liu et al. PLoS One
- Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells
- (2013) Robert W Buckheit et al. Retrovirology
- A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
- (2013) Michael Roche et al. Retrovirology
- Preparation and Activities of Macromolecule Conjugates of the CCR5 Antagonist Maraviroc
- (2013) Shigehiro Asano et al. ACS Medicinal Chemistry Letters
- HIV-1 entry inhibitors: recent development and clinical use
- (2013) Timothy J Henrich et al. Current Opinion in Virology
- Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors
- (2012) Ming-xin Dong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The MOTIVATE trials: maraviroc therapy in antiretroviral treatment-experienced HIV-1-infected patients
- (2012) Steven FL van Lelyveld et al. Expert Review of Anti-Infective Therapy
- In vitro effects of the CCR5 inhibitor maraviroc on human T cell function
- (2012) H. Arberas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant
- (2012) Yuanxi Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemokine Receptor Antagonists
- (2012) James Pease et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIV-1 Resistance to Maraviroc Conferred by a CD4 Binding Site Mutation in the Envelope Glycoprotein gp120
- (2012) A. N. Ratcliff et al. JOURNAL OF VIROLOGY
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease
- (2012) Ran Reshef et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Chemokine Receptor CCR5, a Therapeutic Target for HIV/AIDS Antagonists, Is Critical for Recovery in a Mouse Model of Japanese Encephalitis
- (2012) Maximilian Larena et al. PLoS One
- Effects of sequence changes in the HIV-1 gp41 fusion peptide on CCR5 inhibitor resistance
- (2012) Cleo G. Anastassopoulou et al. VIROLOGY
- Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication
- (2011) Renato Skerlj et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist
- (2011) Changsheng Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1
- (2011) Matthew D. Tallant et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication
- (2011) Renato Skerlj et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of a novel series of cyclic urea as potent CCR5 antagonists
- (2011) Maosheng Duan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats
- (2011) Maosheng Duan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells
- (2011) R. Rossi et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Clinical Utility of Maraviroc
- (2011) Jorge Parra et al. CLINICAL DRUG INVESTIGATION
- Highlights from the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
- (2011) P. Cole et al. DRUGS OF THE FUTURE
- CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection
- (2011) Mieke Gouwy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Chemokine control of West Nile virus infection
- (2011) Jean K. Lim et al. EXPERIMENTAL CELL RESEARCH
- Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial
- (2011) A. MacInnes et al. HIV CLINICAL TRIALS
- Inflammatory chemokine receptors regulate CD8+T cell contraction and memory generation following infection
- (2011) Jacob E. Kohlmeier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Novel 4,4-Disubstituted Piperidine-Based C–C Chemokine Receptor-5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved human Ether-a-go-go Related Gene (hERG) Profile
- (2011) Wieslaw M. Kazmierski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prospective CCR5 Small Molecule Antagonist Compound Design Using a Combined Mutagenesis/Modeling Approach
- (2011) Markus Metz et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry
- (2011) Michael Roche et al. Retrovirology
- HIV coreceptor tropism in antiretroviral treatment-naive patients newly diagnosed at a late stage of HIV infection
- (2010) Benedikt Simon et al. AIDS
- HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry
- (2010) John C. Tilton et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Studies on the structure–activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents
- (2010) Ben Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of N-benzyl-N′-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (II): Modification of the acyl portion
- (2010) Maosheng Duan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series
- (2010) Jutta Wanner et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Evaluation of a 4-aminopiperidine replacement in several series of CCR5 antagonists
- (2010) Rémy C. Lemoine et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Evaluation of a 3-amino-8-azabicyclo[3.2.1]octane replacement in the CCR5 antagonist maraviroc
- (2010) Rémy C. Lemoine et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonists
- (2010) David M. Rotstein et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Exploration of a new series of CCR5 antagonists: Multi-dimensional optimization of a sub-series containing N-substituted pyrazoles
- (2010) Rémy C. Lemoine et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of N-benzyl-N′-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (I): Optimization of the amine portion
- (2010) Maosheng Duan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel (S)-α-phenyl-γ-amino butanamide containing CCR5 antagonists via functionality inversion approach
- (2010) Hu-Shan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- Efficient synthesis and identification of novel propane-1,3-diamino bridged CCR5 antagonists with variation on the basic center carrier
- (2010) Xing Fan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and Safety of Maraviroc Versus Efavirenz, Both With Zidovudine/Lamivudine: 96-Week Results From the MERIT Study
- (2010) Juan Sierra-Madero et al. HIV CLINICAL TRIALS
- An Imidazopiperidine Series of CCR5 Antagonists for the Treatment of HIV: The Discovery ofN-{(1S)-1-(3-Fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)
- (2010) Paul A. Stupple et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5
- (2010) John C. Tilton et al. JOURNAL OF VIROLOGY
- HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells
- (2010) J. M. Pfaff et al. JOURNAL OF VIROLOGY
- CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke
- (2010) Giorgio Luciano Viviani et al. THROMBOSIS AND HAEMOSTASIS
- Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5
- (2010) Robert A. Ogert et al. VIROLOGY
- Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity
- (2010) Chu-Biao Xue et al. ACS Medicinal Chemistry Letters
- HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy
- (2009) Barbara Weiser et al. AIDS
- [2-(4-Phenyl-4-piperidinyl)ethyl]amine based CCR5 antagonists: derivatizations at the N-terminal of the piperidine ring
- (2009) Maosheng Duan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 1-Amido-1-phenyl-3-piperidinylbutanes — CCR5 antagonists for the treatment of HIV. Part 1
- (2009) Christopher G. Barber et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 1-Amido-1-phenyl-3-piperidinylbutanes – CCR5 antagonists for the treatment of HIV: Part 2
- (2009) Christopher G. Barber et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 4,4-Disubstituted cyclohexylamine based CCR5 chemokine receptor antagonists as anti-HIV-1 agents
- (2009) Maosheng Duan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The design and discovery of novel amide CCR5 antagonists
- (2009) David C. Pryde et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Evaluation of secondary amide replacements in a series of CCR5 antagonists as a means to increase intrinsic membrane permeability. Part 1: Optimization of gem-disubstituted azacycles
- (2009) Rémy C. Lemoine et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function
- (2009) Jia Ni et al. BRITISH JOURNAL OF PHARMACOLOGY
- Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
- (2009) Youcef Mehellou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41
- (2009) C. G. Anastassopoulou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced cardiac side-effect potential by introduction of polar groups: Discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo
- (2008) Gebhard Thoma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonist
- (2008) Hanbiao Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
- (2008) Sharon S. Lieberman-Blum et al. CLINICAL THERAPEUTICS
- The Chemokine Receptor CCR5 Plays a Key Role in the Early Memory CD8+ T Cell Response to Respiratory Virus Infections
- (2008) Jacob E. Kohlmeier et al. IMMUNITY
- HIV and Antiretroviral Therapy: Lipid Abnormalities and Associated Cardiovascular Risk in HIV-Infected Patients
- (2008) Donald P Kotler JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Deletion in the Chemokine Receptor 5(CCR5)Gene Is Associated with Tickborne Encephalitis
- (2008) Elin Kindberg et al. JOURNAL OF INFECTIOUS DISEASES
- Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1
- (2008) Wieslaw M. Kazmierski et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo Emergence of Vicriviroc Resistance in a Human Immunodeficiency Virus Type 1 Subtype C-Infected Subject
- (2008) A. M. N. Tsibris et al. JOURNAL OF VIROLOGY
- Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly
- (2008) Yanqing Liu et al. MOLECULES
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120
- (2008) Robert A. Ogert et al. VIROLOGY
- Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists
- (2007) Justin Ernst et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now